Brand, H KAhout, I M Lde Ridder, DWarris, AdiliaLi, YZaalberg, MAndeweg, ARoeleveld, Nde Groot, RWarris, AHermans, P W MFerwerda, GStaal, F J T2017-09-252017-09-252015-07-10Brand, H K, Ahout, I M L, de Ridder, D, Warris, A, Li, Y, Zaalberg, M, Andeweg, A, Roeleveld, N, de Groot, R, Warris, A, Hermans, P W M, Ferwerda, G & Staal, F J T 2015, 'Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection', PloS ONE, vol. 10, no. 7, e0131927. https://doi.org/10.1371/journal.pone.01319271932-6203PubMedCentral: PMC4498630http://hdl.handle.net/2164/9345Funding: Statement of financial support: The study was financially supported by the VIRGO consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK 03012). The authors have indicated they have no personal financial relationships relevant to this article to disclose. Data Availability Statement: The data is accessible at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69606.529006engBiomarkersFemaleGene ExpressionGranulocyte Colony-Stimulating FactorHospitalizationHumansInfantMaleProspective StudiesRespiration, ArtificialRespiratory Syncytial Virus InfectionsSeverity of Illness IndexJournal ArticleResearch Support, Non-U.S. Gov'tR MedicineROlfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) InfectionJournal article10.1371/journal.pone.0131927107